Curaleaf Holdings (CURLF) Prepaid Assets (2019 - 2025)
Curaleaf Holdings (CURLF) posted quarterly Prepaid Assets of $5.9 million for Q4 2025, up 96.67% year-on-year from $3.0 million in Q4 2024, and up 96.67% on a QoQ basis from $3.0 million in Q4 2024.
Curaleaf Holdings (CURLF) Prepaid Assets (2019 - 2025) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Prepaid Assets for 7 consecutive years, with $5.9 million the latest figure, recorded in Q4 2025.
- Quarterly Prepaid Assets rose 96.67% year-over-year to $5.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.9 million (up 96.67% YoY) and the FY2025 annual result came in at $5.9 million, up 96.67% from the prior year.
- Prepaid Assets improved to $5.9 million in Q4 2025 per CURLF's latest filing, from $3.0 million in the prior quarter.
- Over the last five years, Prepaid Assets for CURLF reached as high as $44.5 billion in Q1 2022 and fell as low as $3.0 million in Q4 2024.
- A 5-year average of $3.0 billion and a median of $30.4 million in 2024 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2022 — Prepaid Assets surged 195353.15% — and 2024, when it slumped 90.13%.
- Year by year, Prepaid Assets stood at $35.7 million in 2021, then fell by 19.16% to $28.8 million in 2022, then grew by 5.42% to $30.4 million in 2023, then sank by 90.13% to $3.0 million in 2024, then soared by 96.67% to $5.9 million in 2025.
- According to Business Quant data, Prepaid Assets over the past three periods registered $5.9 million, $3.0 million, and $28.7 million for Q4 2025, Q4 2024, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.90 Mn |
| Dec 31, 2024 | 3.00 Mn |
| Sep 30, 2024 | 28.73 Mn |
| Jun 30, 2024 | 30.42 Mn |
| Dec 31, 2023 | 30.40 Mn |
| Sep 30, 2023 | 36.21 Mn |
| Jun 30, 2023 | 34.99 Mn |
| Dec 31, 2022 | 28.84 Mn |
| Sep 30, 2022 | 31.60 Mn |
| Jun 30, 2022 | 41.38 Mn |
| Mar 31, 2022 | 44.53 Bn |
| Dec 31, 2021 | 35.67 Mn |
| Sep 30, 2021 | 50.31 Mn |
| Jun 30, 2021 | 29.29 Mn |
| Mar 31, 2021 | 22.79 Mn |
| Dec 31, 2020 | 10.14 Mn |
| Sep 30, 2020 | 48.33 Mn |
| Jun 30, 2020 | 26.85 Mn |
| Mar 31, 2020 | 7.69 Mn |
| Dec 31, 2019 | 6.48 Mn |